• 23. Dezember 2024

Debiopharm International SA Presents Positive Preliminary Results From Phase 1 Trials in the Development of the IAP Inhibitor Debio 1143 at the 27th EORTC-NCI-AACR Symposium in Boston

ByDebiopharm Group

Nov 3, 2015

Teile den Beitrag mit Freunden